Wayve, a private AI firm, raised $1.3 billion for its autonomous technology. Investors can't buy Wayve stock yet; IPO timing is unclear. Alternatives include investing in Tesla, Nvidia, Qualcomm, or ...
Neuralink's N1 device aims to restore mobility and vision, presenting significant medical potential. Neuralink is privately held, not publicly traded, limiting direct investment opportunities.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback